FDA Expands Pfizer Boosters For Ages 12 To 15 As Omicron Surges

The FDA has expanded the eligibility for Pfizer's COVID-19 booster shots to include children as young as 12, aligning with the return to school. The booster can now be administered five months after the last dose instead of six. The CDC is yet to make a decision on recommending boosters for younger teens. The timing is crucial as the Omicron variant spreads, and child hospitalizations rise. Many children remain unvaccinated, highlighting the importance of this booster expansion.

What age group has the FDA recently included for Pfizer's COVID booster eligibility?

• Children as young as 10

• Children as young as 16

• Children as young as 12

• Children as young as 14

How soon can eligible individuals receive a booster after their last dose according to the FDA's new guidelines?

• Six months

• Five months

• Four months

• Seven months

Why is the timing of the booster expansion significant?

• It is during the summer break.

• It matches the holiday travel season.

• It aligns with the reopening of schools.

• It coincides with the start of the flu season.

What variant of COVID-19 are the boosters particularly effective against?

• Omicron variant

• Beta variant

• Alpha variant

• Delta variant

What is the current status of child hospitalizations due to COVID-19?

• They are decreasing.

• They are rising.

• They are stable.

• They are non-existent.